These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7429678)

  • 1. Influence of route of administration on haloperidol plasma levels in psychotic patients.
    Bianchetti G; Zarifian E; Poirier-Littre MF; Morselli PL; Deniker P
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):324-7. PubMed ID: 7429678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.
    Neborsky RJ; Janowsky DS; Perel JM; Munson E; Depry D
    J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Haloperidol. Plasma monitoring and hormonal effects of treatment].
    Goyot C; Debray Q; Dugas M; Guay C; Giraud J; Grenier J
    Pathol Biol (Paris); 1985 Dec; 33(10):999-1004. PubMed ID: 2937009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination half-life and bioavailability of haloperidol in schizophrenic patients.
    Magliozzi JR; Hollister LE
    J Clin Psychiatry; 1985 Jan; 46(1):20-1. PubMed ID: 3965439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic of haloperidol decanoate in psychotic patients (author's transl)].
    Parent M; Toussaint C; Driesens F; Gelders Y
    Acta Psychiatr Belg; 1981; 81(4):399-406. PubMed ID: 7331843
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood levels of haloperidol in schizophrenic patients.
    Shvartsburd A; Dekirmenjian H; Smith RC
    J Clin Psychopharmacol; 1983 Feb; 3(1):7-12. PubMed ID: 6833528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma haloperidol and clinical response: a role for reduced haloperidol in antipsychotic activity?
    Shostak M; Perel JM; Stiller RL; Wyman W; Curran S
    J Clin Psychopharmacol; 1987 Dec; 7(6):394-400. PubMed ID: 3429700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum haloperidol concentrations and clinical response in acute psychosis.
    Miller DD; Hershey LA; Duffy JP; Abernethy DR; Greenblatt DJ
    J Clin Psychopharmacol; 1984 Dec; 4(6):305-10. PubMed ID: 6511996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of enrofloxacin given by the oral, intravenous and intramuscular routes in broiler chickens.
    Bugyei K; Black WD; McEwen S
    Can J Vet Res; 1999 Jul; 63(3):193-200. PubMed ID: 10480461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of early neuroleptic response using a uniform haloperidol dose.
    Bowers MB; Swigar ME; Jatlow PI; Hoffman FJ; Goicoechea N
    Int Clin Psychopharmacol; 1987 Jul; 2(3):255-60. PubMed ID: 3693868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral versus intravenous vinorelbine: clinical safety profile.
    Gebbia V; Puozzo C
    Expert Opin Drug Saf; 2005 Sep; 4(5):915-28. PubMed ID: 16111453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of very high doses of haloperidol in the treatment of acute psychotic episodes. Clinical and pharmacokinetic analysis apropos of 15 cases].
    Petit P; Blayac JP; Castelnau D; Billet J; Puech R; Pouget R
    Encephale; 1987; 13(3):127-30. PubMed ID: 3595515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of haloperidol in psychotic patients.
    Cheng YF; Paalzow LK; Bondesson U; Ekblom B; Eriksson K; Eriksson SO; Lindberg A; Lindström L
    Psychopharmacology (Berl); 1987; 91(4):410-4. PubMed ID: 3108922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
    Chouinard G; Safadi G; Beauclair L
    J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma level and effect of low-dose haloperidol in acute psychosis.
    Bleeker JA; Dingemans PM; Frohn-de Winter ML; van de Slooten EP
    Psychopharmacol Bull; 1984; 20(2):317-9. PubMed ID: 6728996
    [No Abstract]   [Full Text] [Related]  

  • 19. Acutely psychotic patients receiving high-dose haloperidol therapy.
    Remington G; Pollock B; Voineskos G; Reed K; Coulter K
    J Clin Psychopharmacol; 1993 Feb; 13(1):41-5. PubMed ID: 8486816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of intramuscular versus oral haloperidol in schizophrenic patients.
    Schaffer CB; Shahid A; Javaid JI; Dysken MW; Davis JM
    J Clin Psychopharmacol; 1982 Aug; 2(4):274-7. PubMed ID: 7119135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.